methionine has been researched along with Sepsis in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (15.38) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 4 (30.77) | 29.6817 |
| 2010's | 4 (30.77) | 24.3611 |
| 2020's | 2 (15.38) | 2.80 |
| Authors | Studies |
|---|---|
| Hu, X; Huang, FR; Ling, M; Tong, P; Wang, D; Wu, BF; Wu, ZQ; Xu, J; Yang, DJ; Zhang, AM | 1 |
| Kaneki, M; Nakazawa, H; Tsuji, D; Yorozu, T | 1 |
| Li, W; Liu, X; Tu, J; Yang, W | 1 |
| Apostolakos, MJ; Arning, E; Bottiglieri, T; Doolin, KP; Gough, MS; Mack, CM; Mooney, RA; Morgan, MAM; Pietropaoli, AP; Wexler, O | 1 |
| Blom, H; Linnebank, M; Moskau, S; Semmler, A; Smith, D; Smulders, Y; Struys, E | 1 |
| Chang, K; Chao, W; Feng, Y; Fischman, AJ; Ichinose, F; Kaneki, M; Kida, K; Mao, J; Scherrer-Crosbie, M; Tamura, Y; Tompkins, RG; Yamada, M; Yang, W; Yao, S; Yu, YM; Zou, L | 1 |
| Calò, LA; De Cristofaro, R; De Filippis, V; Gambaro, G; Lancellotti, S; Maset, F; Oggianu, L; Pozzi, N; Spolaore, B | 1 |
| Harris, TO; Rajagopal, L; Rubens, CE; Shelver, D | 1 |
| Lewis, GS; Löest, CA; Taylor, JB; Thelen, TM; Wang, S | 1 |
| Kitts, D; Moyed, HS; Spurgeon, L; Thrupp, LD; Welch, WD | 1 |
| Lanza-Jacoby, S; Perrotti, D; Phetteplace, H; Sedkova, N | 1 |
| Breuillé, D; Buffière, C; Denis, P; Malmezat, T; Mirand, PP; Obled, C; Pouyet, C | 1 |
| Gavrilă, I; Gidaly, M; Oneşciuc, I | 1 |
13 other study(ies) available for methionine and Sepsis
| Article | Year |
|---|---|
[Metabolomic changes of neonatal sepsis: an exploratory clinical study].
Topics: Ascorbic Acid; Cysteine; Humans; Infant, Newborn; Metabolomics; Methionine; Neonatal Sepsis; Pyruvates; Sepsis | 2022 |
Protective effects of farnesyltransferase inhibitor on sepsis-induced morphological aberrations of mitochondria in muscle and increased circulating mitochondrial DNA levels in mice.
Topics: Animals; DNA, Mitochondrial; Farnesyltranstransferase; Male; Methionine; Mice; Mitochondria; Muscle, Skeletal; Protective Agents; Sepsis; Time Factors | 2021 |
Farnesyltransferase inhibitor FTI-277 inhibits PD-L1 expression on septic spleen lymphocytes and promotes spleen lymphocyte activation.
Topics: Animals; B7-H1 Antigen; Cecum; Cells, Cultured; Disease Models, Animal; Farnesyltranstransferase; Humans; Lymphocyte Activation; Lymphocytes; Male; Methionine; Mice; Mice, Inbred C57BL; NF-kappa B; Programmed Cell Death 1 Receptor; Sepsis; Signal Transduction; Spleen | 2017 |
Methionine Metabolites in Patients With Sepsis.
Topics: Aged; Aged, 80 and over; Case-Control Studies; Catheter-Related Infections; Cohort Studies; Female; Homocysteine; Hospital Mortality; Humans; Intraabdominal Infections; Logistic Models; Male; Methionine; Middle Aged; Prognosis; Prospective Studies; Respiratory Tract Infections; S-Adenosylhomocysteine; S-Adenosylmethionine; Sepsis; Skin Diseases, Infectious; Urinary Tract Infections | 2018 |
Methionine metabolism in an animal model of sepsis.
Topics: Animals; Cysteine; Disease Models, Animal; Glutathione; Homocysteine; Lipopolysaccharides; Male; Methionine; Oxidation-Reduction; Rats; S-Adenosylhomocysteine; S-Adenosylmethionine; Sepsis | 2008 |
Farnesyltransferase inhibitor FTI-277 reduces mortality of septic mice along with improved bacterial clearance.
Topics: Animals; Bacterial Load; Cecum; Cytokines; Drug Evaluation, Preclinical; Enzyme Inhibitors; Farnesyltranstransferase; Heart Function Tests; Hemodynamics; HMGB1 Protein; Lung; Male; Methionine; Mice; Mice, Inbred C57BL; Protein Prenylation; Sepsis; Spleen; T-Lymphocytes | 2011 |
Oxidation of Met1606 in von Willebrand factor is a risk factor for thrombotic and septic complications in chronic renal failure.
Topics: ADAM Proteins; ADAMTS13 Protein; Adhesins, Bacterial; Adult; Amino Acid Sequence; Case-Control Studies; Female; Humans; Kidney Failure, Chronic; Male; Methionine; Middle Aged; Molecular Sequence Data; Molecular Weight; Oxidation-Reduction; Peptide Fragments; Platelet Activation; Protein Multimerization; Renal Dialysis; Risk Factors; Sepsis; Thrombosis; von Willebrand Factor | 2012 |
MtaR, a regulator of methionine transport, is critical for survival of group B streptococcus in vivo.
Topics: Animals; Animals, Newborn; Bacterial Proteins; Disease Models, Animal; Gene Expression Regulation, Bacterial; Humans; Methionine; Mutation; Rats; Sepsis; Streptococcal Infections; Streptococcus agalactiae; Transcription Factors | 2003 |
Intrauterine bacterial inoculation and level of dietary methionine alter amino acid metabolism in nulliparous yearling ewes.
Topics: Amino Acids; Animal Feed; Animal Nutritional Physiological Phenomena; Animals; Dietary Proteins; Dose-Response Relationship, Drug; Female; Methionine; Nutritional Requirements; Random Allocation; Sepsis; Sheep; Sheep Diseases; Splanchnic Circulation; Uterine Diseases | 2007 |
Unique temperature-sensitive nutritional requirements of bacteremic Escherichia coli isolates.
Topics: Culture Media; Escherichia coli; Escherichia coli Infections; Methionine; Niacin; Nicotinic Acids; Sepsis; Temperature | 1981 |
Sepsis-induced regulation of lipoprotein lipase expression in rat adipose tissue and soleus muscle.
Topics: Adipose Tissue; Animals; Cohort Studies; Cysteine; Epididymis; Escherichia coli; Fasting; Gene Expression Regulation, Enzymologic; Lipoprotein Lipase; Male; Methionine; Muscle, Skeletal; Rats; Rats, Inbred Lew; RNA, Messenger; Sepsis | 1997 |
Methionine transsulfuration is increased during sepsis in rats.
Topics: Animals; Anorexia; Cystathionine gamma-Lyase; Cysteine; Eating; Escherichia coli Infections; Liver; Male; Methionine; Nitrogen Isotopes; Organ Size; Rats; Rats, Sprague-Dawley; Sepsis; Sulfur; Sulfur Radioisotopes | 2000 |
[Hepatic function test with methionine-S35 in grave infectious syndromes].
Topics: Gastrointestinal Diseases; Hepatitis; Humans; Liver; Liver Function Tests; Meningitis; Methionine; Sepsis; Sulfur Isotopes; Typhoid Fever | 1968 |